PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Neurocritical Care10.18700/jnc.2100282021142103-108Successful treatment with rituximab in a patient with lupus cerebritis and posterior reversible encephalopathy syndrome: a case reportSaemi Choi, Young Seo Kimhttp://e-jnc.org/upload/pdf/jnc-210028.pdf, http://e-jnc.org/journal/view.php?doi=10.18700/jnc.210028, http://e-jnc.org/upload/pdf/jnc-210028.pdf
Reactions Weekly10.1007/s40278-022-17260-8202219101425-425Rituximabhttps://link.springer.com/content/pdf/10.1007/s40278-022-17260-8.pdf, https://link.springer.com/article/10.1007/s40278-022-17260-8/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-17260-8.pdf
Reactions Weekly10.1007/s40278-015-0763-y201515511211-211Rituximabhttp://link.springer.com/content/pdf/10.1007/s40278-015-0763-y.pdf, http://link.springer.com/article/10.1007/s40278-015-0763-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-0763-y
Reactions Weekly10.1007/s40278-015-8818-7201515431194-194Rituximabhttp://link.springer.com/content/pdf/10.1007/s40278-015-8818-7.pdf, http://link.springer.com/article/10.1007/s40278-015-8818-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-8818-7
Reactions Weekly10.1007/s40278-016-16626-6201615971184-184Rituximabhttp://link.springer.com/content/pdf/10.1007/s40278-016-16626-6.pdf, http://link.springer.com/article/10.1007/s40278-016-16626-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-016-16626-6
Reactions Weekly10.1007/s40278-018-49776-7201817121487-487Rituximabhttp://link.springer.com/content/pdf/10.1007/s40278-018-49776-7.pdf, http://link.springer.com/article/10.1007/s40278-018-49776-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-49776-7.pdf
Reactions Weekly10.1007/s40278-019-58366-x201917411134-134Immunosuppressants/rituximabhttp://link.springer.com/article/10.1007/s40278-019-58366-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-019-58366-x.pdf, http://link.springer.com/content/pdf/10.1007/s40278-019-58366-x.pdf
Reactions Weekly10.1007/s40278-020-82633-020201819190-90Corticosteroids/cyclophosphamide/rituximabhttps://link.springer.com/content/pdf/10.1007/s40278-020-82633-0.pdf, https://link.springer.com/article/10.1007/s40278-020-82633-0/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-020-82633-0.pdf
Reactions Weekly10.1007/s40278-015-4447-420151565188-88Cyclophosphamide/methylprednisolone/rituximabhttp://link.springer.com/content/pdf/10.1007/s40278-015-4447-4.pdf, http://link.springer.com/article/10.1007/s40278-015-4447-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-4447-4
Reactions Weekly10.1007/s40278-020-74077-6202017871439-439Rituximabhttp://link.springer.com/content/pdf/10.1007/s40278-020-74077-6.pdf, http://link.springer.com/article/10.1007/s40278-020-74077-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-020-74077-6.pdf